Page last updated: 2024-08-22

trimetazidine and Inflammatory Response Syndrome, Systemic

trimetazidine has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eslami Far, A; Jahandideh, S; Kadivar, M; Khatami, S	1

Other Studies

1 other study(ies) available for trimetazidine and Inflammatory Response Syndrome, Systemic

Article	Year
Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model. Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup2 Topics: Animals; Cell Line; Culture Media, Conditioned; Cytokines; Diazoxide; Disease Models, Animal; Human Embryonic Stem Cells; Humans; Kidney; Leupeptins; Lipopolysaccharides; Lung; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Survival Analysis; Systemic Inflammatory Response Syndrome; Trimetazidine	2018

Article

Year

Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model.

Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup2

Topics: Animals; Cell Line; Culture Media, Conditioned; Cytokines; Diazoxide; Disease Models, Animal; Human Embryonic Stem Cells; Humans; Kidney; Leupeptins; Lipopolysaccharides; Lung; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Survival Analysis; Systemic Inflammatory Response Syndrome; Trimetazidine

2018